MRCATMiniature Remote Controlled Aerial Target
References in periodicals archive ?
Philips has achieved 510(k) clearance from the Food and Drug Administration (FDA) for its MRCAT (Magnetic Resonance for Calculating ATtenuation) solution as part of its Ingenia MR-RT platform.
As part of its Ingenia MR-RT platform for MR simulation, Philips new MRCAT solution allows physicians treating prostate cancer patients to adopt a single-modality imaging approach that provides high quality soft-tissue contrast for target delineation, as well as density information for dose calculations.